Life sciences · Observational Study
ClinicalTrials.gov · October 7, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT04474301). This is a study registration, not published results. Lead sponsor: M.D. Anderson Cancer Center. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 1152 participants (ESTIMATED). Conditions: COVID-19 Infection, Melanoma. Interventions: OTHER: Survey Administration. Primary outcome measures: Experiences during the COVID-19 pandemic , Survey completion Up to 2 months; COVID-19-specific psychological distress , Survey completion Up to 2 months; COVID-19-specific health , Survey completion Up to 2 months; COVID-19-specific financial and social disruptions , Survey completion Up to 2 months; COVID-19-specific perceived benefits and social support , Survey completion Up to 2 months; COVID-19-specific health related quality of life (HRQoL) , Survey completion Up to 2 months; Effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL , Survey completion Up to 2 months; Prior lifestyle data , Survey completion Up to 2 months. Brief summary: The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.